October 31, 2016
Acessa Health (formerly Halt Medical) licenses InnerOptic's Aim
Halt Medical announces an exclusive license to InnerOptic's patented AIM guidance software, for the Halt Acessa Guidance System. The Acessa Guidance System incorporates Aim with electromagnetic tracking technology and radiofrequency ablation to treat symptomatic uterine fibroids laparoscopically. When coupled with ultrasound, it provides instant feedback of device trajectory to the targeted fibroid and tracks the surgical instruments in real time. This is the first time in history that this technology has been applied in the field of gynecology.
June 14, 2016
InnerOptic issued patent on 3D needle navigation
InnerOptic was issued patent 9,675,319 by the US Patent Office covering 3D needle navigation, titled "Image Management in Image-Guided Medical Procedures." This groundbreaking invention covers aspects of InnerOptic's Spotlight system and represents an important advancement in visualization and navigation for CT/MRI data sets.
Februrary 23, 2016
UNC issued foundational patent on 3D needle navigation; exclusively licensed to InnerOptic
The University of North Carolina at Chapel Hill was issued patent 9,265,572, titled "Methods, Systems, and Computer Readable Media for Image Guided Ablation." This groundbreaking patent covers numerous aspects of 3D needle navigation has been exclusively licensed to InnerOptic Technology.
June 13, 2017
InnerOptic issued patent on Augmented Reality for 3D needle navigation
InnerOptic was issued patent 9,675,319 by the the US Patent Office, titled "Image Management in Image-Guided Medical Procedures." This groundbreaking extends InnerOptic's 3D needle navigation in Magic Loupe™ for use with Augmented Reality (AR) glasses.